Bigger and better: how Pfizer redefined erectile dysfunction

PLoS Med. 2006 Apr;3(4):e132. doi: 10.1371/journal.pmed.0030132. Epub 2006 Apr 11.

Abstract

Lexchin examines how Pfizer transformed sildenafil from an effective product for erectile dysfunction due to illness or injury into a drug that healthy men can use to enhance their erections.

MeSH terms

  • Adolescent
  • Adult
  • Advertising*
  • Age Factors
  • Drug Costs
  • Drug Industry*
  • Erectile Dysfunction / drug therapy*
  • Erectile Dysfunction / epidemiology
  • Erectile Dysfunction / etiology
  • Erectile Dysfunction / psychology
  • Evidence-Based Medicine
  • Humans
  • Insurance Coverage
  • Life Style*
  • Male
  • Middle Aged
  • Piperazines / economics
  • Piperazines / therapeutic use*
  • Prevalence
  • Purines
  • Resource Allocation
  • Severity of Illness Index
  • Sildenafil Citrate
  • Social Conditions
  • Sulfones
  • Treatment Outcome
  • Vasodilator Agents / economics
  • Vasodilator Agents / therapeutic use*

Substances

  • Piperazines
  • Purines
  • Sulfones
  • Vasodilator Agents
  • Sildenafil Citrate